RenovoRx, Inc.
NASDAQ:RNXTBiotechnology
-$0.01 today
- Market cap
- $54.04M
- Beta
- 0.99
- P/E (TTM)
- -3.4
- EPS (TTM)
- -$0.32
Volume 0.84M
Average 0.29M
RNXT Total Non-current Assets
All assets not expected to be converted to cash within one year.
RenovoRx, Inc.NASDAQ: RNXT
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 9.3% from a year ago
Total non-current assets stood at $244K at the end of Q1 FY2026, down 9.3% from a year earlier and up 20.8% from the prior quarter.
Context
- Total non-current assets amounted to 1.7% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total non-current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -9.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 202K USD
- Year-over-year change
- -30.3%
- 4-year CAGR
- +140.9%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 202K | -30.3% |
| FY2024 | 2024-12-31 | 290K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 6K | — |
Total Non-current Assets vs competitors
How RNXT compares with its peers on the latest reported figures
- RNXT's Mar 2026 total non-current assets of $244K is the 3rd highest of the 6 companies compared; the peer median is $165.81K.
- Its year-over-year change of -9.3% is the 2nd highest of 5, against a peer median of -16.8%.
- Total non-current assets amounts to 1.7% of total assets for RNXT, versus a peer median of 2.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $95.01M | -15.3% | -36.3% | 88.5% | |
| Mar 2026 | $6.6M | -18.3% | -15.6% | 34.4% | |
| Mar 2026 | $244K | -9.3% | — | 1.7% | |
| Mar 2026 | $165.81K | -39.3% | +1170.0% | 2.3% | |
| Mar 2026 | $7.52K | +168.5% | -76.4% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RNXT) | $165.81K | -16.8% | -26.0% | 2.3% | |
Competitors are the stored peer set for RNXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
RenovoRx, Inc.
NASDAQ:RNXT
Intrinsic Alpha fair value
Locked
Current Price
$1.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.